{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T06:29:59Z","timestamp":1776752999087,"version":"3.51.2"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,11,28]],"date-time":"2013-11-28T00:00:00Z","timestamp":1385596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,11,28]],"date-time":"2013-11-28T00:00:00Z","timestamp":1385596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Immun"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1038\/gene.2013.62","type":"journal-article","created":{"date-parts":[[2013,11,28]],"date-time":"2013-11-28T09:55:05Z","timestamp":1385632505000},"page":"47-53","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["HLA-DPB1 and anti-HBs titer kinetics in hepatitis B booster recipients who completed primary hepatitis B vaccination during infancy"],"prefix":"10.1038","volume":"15","author":[{"given":"T-W","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C-C","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H-W","family":"Chang Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S-K","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T-Y","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H H","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L-Y","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,11,28]]},"reference":[{"key":"BFgene201362_CR1","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","volume":"142","author":"HB El-Serag","year":"2012","unstructured":"El-Serag HB . Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 2012; 142: 1264\u20131273 e1.","journal-title":"Gastroenterology"},{"key":"BFgene201362_CR2","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1002\/hep.22881","volume":"49","author":"TJ Liang","year":"2009","unstructured":"Liang TJ . Hepatitis B: the virus and disease. Hepatology 2009; 49: S13\u2013S21.","journal-title":"Hepatology"},{"key":"BFgene201362_CR3","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jhep.2007.11.011","volume":"48","author":"G Fattovich","year":"2008","unstructured":"Fattovich G, Bortolotti F, Donato F . Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. JHepatol 2008; 48: 335\u2013352.","journal-title":"JHepatol"},{"key":"BFgene201362_CR4","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1056\/NEJMra031087","volume":"350","author":"D Ganem","year":"2004","unstructured":"Ganem D, Prince AM . Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 2004; 350: 1118\u20131129.","journal-title":"N Engl J Med"},{"key":"BFgene201362_CR5","doi-asserted-by":"publisher","first-page":"333","DOI":"10.7326\/0003-4819-142-5-200503010-00008","volume":"142","author":"BJ McMahon","year":"2005","unstructured":"McMahon BJ, Bruden DL, Petersen KM, Bulkow LR, Parkinson AJ, Nainan O et al. Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up. Ann Intern Med 2005; 142: 333\u2013341.","journal-title":"Ann Intern Med"},{"key":"BFgene201362_CR6","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1001\/jama.1987.03390190075023","volume":"257","author":"DS Chen","year":"1987","unstructured":"Chen DS, Hsu NH, Sung JL, Hsu TC, Hsu ST, Kuo YT et al. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA 1987; 257: 2597\u20132603.","journal-title":"JAMA"},{"key":"BFgene201362_CR7","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1001\/jama.1996.03540110060032","volume":"276","author":"HL Chen","year":"1996","unstructured":"Chen HL, Chang MH, Ni YH, Hsu HY, Lee PI, Lee CY et al. Seroepidemiology of hepatitis B virus infection in children: Ten years of mass vaccination in Taiwan. JAMA 1996; 276: 906\u2013908.","journal-title":"JAMA"},{"key":"BFgene201362_CR8","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1002\/hep.510300511","volume":"30","author":"HY Hsu","year":"1999","unstructured":"Hsu HY, Chang MH, Liaw SH, Ni YH, Chen HL . Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology 1999; 30: 1312\u20131317.","journal-title":"Hepatology"},{"key":"BFgene201362_CR9","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.vaccine.2005.08.062","volume":"24","author":"SN Lu","year":"2006","unstructured":"Lu SN, Chen CH, Chen TM, Lee PL, Wang JH, Tung HD et al. Hepatitis B virus infection in adolescents in a rural township-15 years subsequent to mass hepatitis B vaccination in Taiwan. Vaccine 2006; 24: 759\u2013765.","journal-title":"Vaccine"},{"key":"BFgene201362_CR10","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/hep.23543","volume":"51","author":"CF Jan","year":"2010","unstructured":"Jan CF, Huang KC, Chien YC, Greydanus DE, Davies HD, Chiu TY et al. Determination of immune memory to hepatitis B vaccination through early booster response in college students. Hepatology 2010; 51: 1547\u20131554.","journal-title":"Hepatology"},{"key":"BFgene201362_CR11","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1002\/hep.20490","volume":"40","author":"CY Lu","year":"2004","unstructured":"Lu CY, Chiang BL, Chi WK, Chang MH, Ni YH, Hsu HM et al. Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination. Hepatology 2004; 40: 1415\u20131420.","journal-title":"Hepatology"},{"key":"BFgene201362_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/hep.25988","volume":"57","author":"TW Wu","year":"2013","unstructured":"Wu TW, Lin HH, Wang LY . Chronic hepatitis B infection in adolescents who received primary infantile vaccination. Hepatology 2013; 57: 37\u201345.","journal-title":"Hepatology"},{"key":"BFgene201362_CR13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1399-0039.1990.tb01757.x","volume":"35","author":"M Varla-Leftherioti","year":"1990","unstructured":"Varla-Leftherioti M, Papanicolaou M, Spyropoulou M, Vallindra H, Tsiroyianni P, Tassopoulos N et al. HLA-associated non-responsiveness to hepatitis B vaccine. Tissue Antigens 1990; 35: 60\u201363.","journal-title":"Tissue Antigens"},{"key":"BFgene201362_CR14","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/j.1399-0039.1998.tb03001.x","volume":"51","author":"I Desombere","year":"1998","unstructured":"Desombere I, Willems A, Leroux-Roels G . Response to hepatitis B vaccine: multiple HLA genes are involved. Tissue Antigens 1998; 51: 593\u2013604.","journal-title":"Tissue Antigens"},{"key":"BFgene201362_CR15","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1002\/eji.1830220733","volume":"22","author":"K Hatae","year":"1992","unstructured":"Hatae K, Kimura A, Okubo R, Watanabe H, Erlich HA, Ueda K et al. Genetic control of nonresponsiveness to hepatitis B virus vaccine by an extended HLA haplotype. Eur J Immunol 1992; 22: 1899\u20131905.","journal-title":"Eur J Immunol"},{"key":"BFgene201362_CR16","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1006\/clim.2000.4933","volume":"97","author":"M Martinetti","year":"2000","unstructured":"Martinetti M, De Silvestri A, Belloni C, Pasi A, Tinelli C, Pistorio A et al. Humoral response to recombinant hepatitis B virus vaccine at birth: role of HLA and beyond. Clin Immunol 2000; 97: 234\u2013240.","journal-title":"Clin Immunol"},{"key":"BFgene201362_CR17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1399-0039.1997.tb02827.x","volume":"50","author":"AB McDermott","year":"1997","unstructured":"McDermott AB, Zuckerman JN, Sabin CA, Marsh SG, Madrigal JA . Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination. Tissue Antigens 1997; 50: 8\u201314.","journal-title":"Tissue Antigens"},{"key":"BFgene201362_CR18","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/0264-410X(93)90173-U","volume":"11","author":"HY Hsu","year":"1993","unstructured":"Hsu HY, Chang MH, Ho HN, Hsieh RP, Lee SD, Chen DS et al. Association of HLA-DR14-DR52 with low responsiveness to hepatitis B vaccine in Chinese residents in Taiwan. Vaccine 1993; 11: 1437\u20131440.","journal-title":"Vaccine"},{"key":"BFgene201362_CR19","doi-asserted-by":"publisher","first-page":"3414","DOI":"10.1016\/j.vaccine.2008.04.038","volume":"26","author":"HH Lin","year":"2008","unstructured":"Lin HH, Liao HW, Lin SK, Wang LY . HLA and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination. Vaccine 2008; 26: 3414\u20133420.","journal-title":"Vaccine"},{"key":"BFgene201362_CR20","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1007\/s00439-013-1320-5","volume":"132","author":"TW Wu","year":"2013","unstructured":"Wu TW, Chu CC, Ho TY, Chang Liao HW, Lin SK, Lin M et al. Responses to booster hepatitis B vaccination are significantly correlated with genotypes of human leukocyte antigen (HLA)-DPB1 in neonatally vaccinated adolescents. Hum Genet 2013; 132: 1131\u20131139.","journal-title":"Hum Genet"},{"key":"BFgene201362_CR21","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/ng.348","volume":"41","author":"Y Kamatani","year":"2009","unstructured":"Kamatani Y, Wattanapokayakit S, Ochi H, Kawaguchi T, Takahashi A, Hosono N et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet 2009; 41: 591\u2013595.","journal-title":"Nat Genet"},{"key":"BFgene201362_CR22","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/hep.24048","volume":"53","author":"X Guo","year":"2011","unstructured":"Guo X, Zhang Y, Li J, Ma J, Wei Z, Tan W et al. Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population. Hepatology 2011; 53: 422\u2013428.","journal-title":"Hepatology"},{"key":"BFgene201362_CR23","doi-asserted-by":"publisher","first-page":"e24221","DOI":"10.1371\/journal.pone.0024221","volume":"6","author":"J Li","year":"2011","unstructured":"Li J, Yang D, He Y, Wang M, Wen Z, Liu L et al. Associations of HLA-DP variants with hepatitis B virus infection in southern and northern Han Chinese populations: a multicenter case-control study. PLoS One 2011; 6: e24221.","journal-title":"PLoS One"},{"key":"BFgene201362_CR24","doi-asserted-by":"publisher","first-page":"e17608","DOI":"10.1371\/journal.pone.0017608","volume":"6","author":"L Wang","year":"2011","unstructured":"Wang L, Wu XP, Zhang W, Zhu DH, Wang Y, Li YP et al. Evaluation of genetic susceptibility loci for chronic hepatitis B in Chinese: two independent case-control studies. PLoS One 2011; 6: e17608.","journal-title":"PLoS One"},{"key":"BFgene201362_CR25","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/S0140-6736(75)92610-0","volume":"1","author":"PC Doherty","year":"1975","unstructured":"Doherty PC, Zinkernagel RM . A biological role for the major histocompatibility antigens. Lancet 1975; 1: 1406\u20131409.","journal-title":"Lancet"},{"key":"BFgene201362_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/ng0997-11","volume":"17","author":"MR Thursz","year":"1997","unstructured":"Thursz MR, Thomas HC, Greenwood BM, Hill AV . Heterozygote advantage for HLA class-II type in hepatitis B virus infection. Nat genet 1997; 17: 11\u201312.","journal-title":"Nat genet"},{"key":"BFgene201362_CR27","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1126\/science.283.5408.1748","volume":"283","author":"M Carrington","year":"1999","unstructured":"Carrington M, Nelson GW, Martin MP, Kissner T, Vlahov D, Goedert JJ et al. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 1999; 283: 1748\u20131752.","journal-title":"Science"},{"key":"BFgene201362_CR28","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1002\/hep.21889","volume":"46","author":"P Hraber","year":"2007","unstructured":"Hraber P, Kuiken C, Yusim K . Evidence for human leukocyte antigen heterozygote advantage against hepatitis C virus infection. Hepatology 2007; 46: 1713\u20131721.","journal-title":"Hepatology"},{"key":"BFgene201362_CR29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3390\/v1020091","volume":"1","author":"A Bertoletti","year":"2009","unstructured":"Bertoletti A, Tan AT, Gehring AJ . HBV-Specific Adaptive Immunity. Viruses 2009; 1: 91\u2013103.","journal-title":"Viruses"},{"key":"BFgene201362_CR30","first-page":"1472","volume":"99","author":"FV Chisari","year":"1997","unstructured":"Chisari FV . Cytotoxic T cells and viral hepatitis. J ClinInvest 1997; 99: 1472\u20131477.","journal-title":"J ClinInvest"},{"key":"BFgene201362_CR31","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/S0952-7915(96)80034-3","volume":"8","author":"LG Guidotti","year":"1996","unstructured":"Guidotti LG, Chisari FV . To kill or to cure: options in host defense against viral infection. Curr Opin Immunol 1996; 8: 478\u2013483.","journal-title":"Curr Opin Immunol"},{"key":"BFgene201362_CR32","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1136\/bmj.2.6144.1056","volume":"2","author":"A Alberti","year":"1978","unstructured":"Alberti A, Diana S, Sculard GH, Eddleston AL, Williams R . Detection of a new antibody system reacting with Dane particles in hepatitis B virus infection. Br Med J 1978; 2: 1056\u20131058.","journal-title":"Br Med J"},{"key":"BFgene201362_CR33","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nri1573","volume":"5","author":"B Rehermann","year":"2005","unstructured":"Rehermann B, Nascimbeni M . Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2005; 5: 215\u2013229.","journal-title":"Nat Rev Immunol"},{"key":"BFgene201362_CR34","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.virol.2010.12.016","volume":"411","author":"IJ Amanna","year":"2011","unstructured":"Amanna IJ, Slifka MK . Contributions of humoral and cellular immunity to vaccine-induced protection in humans. Virology 2011; 411: 206\u2013215.","journal-title":"Virology"},{"key":"BFgene201362_CR35","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1126\/science.283.5406.1277","volume":"283","author":"CC Whitacre","year":"1999","unstructured":"Whitacre CC, Reingold SC, O'Looney PA . A gender gap in autoimmunity. Science 1999; 283: 1277\u20131278.","journal-title":"Science"},{"key":"BFgene201362_CR36","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1530\/eje.0.1430031","volume":"143","author":"JA Giron-Gonzalez","year":"2000","unstructured":"Giron-Gonzalez JA, Moral FJ, Elvira J, Garcia-Gil D, Guerrero F, Gavilan I et al. Consistent production of a higher TH1:TH2 cytokine ratio by stimulated T cells in men compared with women. Eur J Endocrinol 2000; 143: 31\u201336.","journal-title":"Eur J Endocrinol"},{"key":"BFgene201362_CR37","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1006\/cyto.2001.0900","volume":"14","author":"RW McMurray","year":"2001","unstructured":"McMurray RW, Ndebele K, Hardy KJ, Jenkins JK . 17-beta-estradiol suppresses IL-2 and IL-2 receptor. Cytokine 2001; 14: 324\u2013333.","journal-title":"Cytokine"},{"key":"BFgene201362_CR38","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.jcv.2013.07.003","volume":"58","author":"AP Vermeiren","year":"2013","unstructured":"Vermeiren AP, Hoebe CJ, Dukers-Muijrers NH . High non-responsiveness of males and the elderly to standard hepatitis B vaccination among a large cohort of healthy employees. J Clin Virol 2013; 58: 262\u2013264.","journal-title":"J Clin Virol"},{"key":"BFgene201362_CR39","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1182\/blood.V95.6.2059","volume":"95","author":"KL Medina","year":"2000","unstructured":"Medina KL, Strasser A, Kincade PW . Estrogen influences the differentiation, proliferation and survival of early B-lineage precursors. Blood 2000; 95: 2059\u20132067.","journal-title":"Blood"},{"key":"BFgene201362_CR40","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/immu.200310027","volume":"33","author":"A Maret","year":"2003","unstructured":"Maret A, Coudert JD, Garidou L, Foucras G, Gourdy P, Krust A et al. Estradiol enhances primary antigen-specific CD4 T cell responses and Th1 development in vivo. Essential role of estrogen receptor alpha expression in hematopoietic cells. Eur J Immunol 2003; 33: 512\u2013521.","journal-title":"Eur J Immunol"},{"key":"BFgene201362_CR41","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1172\/JCI0214873","volume":"109","author":"CM Grimaldi","year":"2002","unstructured":"Grimaldi CM, Cleary J, Dagtas AS, Moussai D, Diamond B . Estrogen alters thresholds for B cell apoptosis and activation. J Clin Invest 2002; 109: 1625\u20131633.","journal-title":"J Clin Invest"},{"key":"BFgene201362_CR42","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/S0091-6749(99)70503-8","volume":"103","author":"N Kanda","year":"1999","unstructured":"Kanda N, Tamaki K . Estrogen enhances immunoglobulin production by human PBMCs. J Allergy Clin Immunol 1999; 103: 282\u2013288.","journal-title":"J Allergy Clin Immunol"},{"key":"BFgene201362_CR43","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.1210\/en.2005-0284","volume":"146","author":"KM Palaszynski","year":"2005","unstructured":"Palaszynski KM, Smith DL, Kamrava S, Burgoyne PS, Arnold AP, Voskuhl RR . A yin-yang effect between sex chromosome complement and sex hormones on the immune response. Endocrinology 2005; 146: 3280\u20133285.","journal-title":"Endocrinology"},{"key":"BFgene201362_CR44","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1084\/jem.20070850","volume":"205","author":"DL Smith-Bouvier","year":"2008","unstructured":"Smith-Bouvier DL, Divekar AA, Sasidhar M, Du S, Tiwari-Woodruff SK, King JK et al. A role for sex chromosome complement in the female bias in autoimmune disease. J Exp Med 2008; 205: 1099\u20131108.","journal-title":"J Exp Med"},{"key":"BFgene201362_CR45","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1056\/NEJMoa066092","volume":"357","author":"IJ Amanna","year":"2007","unstructured":"Amanna IJ, Carlson NE, Slifka MK . Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med 2007; 357: 1903\u20131915.","journal-title":"N Engl J Med"},{"key":"BFgene201362_CR46","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1002\/(SICI)1521-4141(199904)29:04<1406::AID-IMMU1406>3.0.CO;2-P","volume":"29","author":"H Leyendeckers","year":"1999","unstructured":"Leyendeckers H, Odendahl M, Lohndorf A, Irsch J, Spangfort M, Miltenyi S et al. Correlation analysis between frequencies of circulating antigen-specific IgG-bearing memory B cells and serum titers of antigen-specific IgG. Eur J Immunol 1999; 29: 1406\u20131417.","journal-title":"Eur J Immunol"},{"key":"BFgene201362_CR47","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1002\/art.11181","volume":"48","author":"G Cambridge","year":"2003","unstructured":"Cambridge G, Leandro MJ, Edwards JC, Ehrenstein MR, Salden M, Bodman-Smith M et al. Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis. Arthritis Rheum 2003; 48: 2146\u20132154.","journal-title":"Arthritis Rheum"},{"key":"BFgene201362_CR48","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/j.1365-3083.2011.02544.x","volume":"73","author":"VT Chu","year":"2011","unstructured":"Chu VT, Beller A, Nguyen TT, Steinhauser G, Berek C . The long-term survival of plasma cells. Scand J Immunol 2011; 73: 508\u2013511.","journal-title":"Scand J Immunol"},{"key":"BFgene201362_CR49","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1002\/1521-4141(200204)32:4<923::AID-IMMU923>3.0.CO;2-1","volume":"32","author":"RA Manz","year":"2002","unstructured":"Manz RA, Radbruch A . Plasma cells for a lifetime? Eur J Immunol 2002; 32: 923\u2013927.","journal-title":"Eur J Immunol"},{"key":"BFgene201362_CR50","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1084\/jem.20011626","volume":"195","author":"BP O'Connor","year":"2002","unstructured":"O'Connor BP, Cascalho M, Noelle RJ . Short-lived and long-lived bone marrow plasma cells are derived from a novel precursor population. J Exp Med 2002; 195: 737\u2013745.","journal-title":"J Exp Med"},{"key":"BFgene201362_CR51","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1182\/blood-2007-09-110858","volume":"111","author":"E Belnoue","year":"2008","unstructured":"Belnoue E, Pihlgren M, McGaha TL, Tougne C, Rochat AF, Bossen C et al. APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells. Blood 2008; 111: 2755\u20132764.","journal-title":"Blood"},{"key":"BFgene201362_CR52","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/eji.200425442","volume":"35","author":"JI Ellyard","year":"2005","unstructured":"Ellyard JI, Avery DT, Mackay CR, Tangye SG . Contribution of stromal cells to the migration, function and retention of plasma cells in human spleen: potential roles of CXCL12, IL-6 and CD54. Eur J Immunol 2005; 35: 699\u2013708.","journal-title":"Eur J Immunol"},{"key":"BFgene201362_CR53","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1182\/blood-2004-08-2992","volume":"105","author":"G Muehlinghaus","year":"2005","unstructured":"Muehlinghaus G, Cigliano L, Huehn S, Peddinghaus A, Leyendeckers H, Hauser AE et al. Regulation of CXCR3 and CXCR4 expression during terminal differentiation of memory B cells into plasma cells. Blood 2005; 105: 3965\u20133971.","journal-title":"Blood"},{"key":"BFgene201362_CR54","volume-title":"Sequencing based typing for HLA-DPB1: strategy for ABI equipment.","author":"A van der Zwan","year":"2006","unstructured":"van der Zwan A, Rozemuller E, Tilanus M . Sequencing based typing for HLA-DPB1: strategy for ABI equipment.. IHWG Press: Seattle, WA, USA, 2006."},{"key":"BFgene201362_CR55","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1399-0039.1995.tb02507.x","volume":"46","author":"LF Versluis","year":"1995","unstructured":"Versluis LF, Rozemuller EH, Duran K, Tilanus MG . Ambiguous DPB1 allele combinations resolved by direct sequencing of selectively amplified alleles. Tissue antigens 1995; 46: 345\u2013349.","journal-title":"Tissue antigens"}],"container-title":["Genes &amp; Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gene201362.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gene201362","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gene201362.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T17:12:12Z","timestamp":1647969132000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gene201362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,28]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["BFgene201362"],"URL":"https:\/\/doi.org\/10.1038\/gene.2013.62","relation":{},"ISSN":["1466-4879","1476-5470"],"issn-type":[{"value":"1466-4879","type":"print"},{"value":"1476-5470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,28]]},"assertion":[{"value":"11 September 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}